Eli Lilly and Company · LLY
As of the latest run, Eli Lilly and Company (LLY) scores 77/100 overall — one of the strongest profiles the engine is surfacing right now. Its strongest dimension: profitability (100/100); the one that most warrants attention: financial health (44/100).
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
Profitability comes in at 100/100 — above-average margins and return on capital. Growth comes in at 100/100 — sustained revenue growth. Valuation comes in at 88/100 — a reasonable price relative to the stock's own valuation history.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
Financial health falls to 44/100 — a balance sheet under strain, on debt or liquidity.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.